Fig. 6. Relation between oligodeoxynucleotide (ODN) length and dose-normalized area under the curve (AUC) at the L4 and L1 intrathecal sampling sites.

Fig. 6. Relation between oligodeoxynucleotide (ODN) length and dose-normalized area under the curve (AUC) at the L4 and L1 intrathecal sampling sites.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal